The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Fashafsha Z.Z.

Sechenov First Moscow State Medical University

Mesitskaya D.F.

Sechenov First Moscow State Medical University

Kopylov F.Iu.

Sechenov First Moscow State Medical University

Salpagarova Z.K.

Sechenov First Moscow State Medical University

Bykova A.A.

Sechenov First Moscow State Medical University

Diagnostic aspects of cardiovascular complications following chemotherapy

Authors:

Fashafsha Z.Z., Mesitskaya D.F., Kopylov F.Iu., Salpagarova Z.K., Bykova A.A.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(1): 40‑45

DOI: 10.17116/kardio20221501140

Read: 3149 times

Contact the author
Table of contents

DIAGNOSTIC ASPECTS OF CARDIOVASCULAR COMPLICATIONS FOLLOWING CHEMOTHERAPY
DIAGNOSTIC ASPECTS OF CARDIOVASCULAR COMPLICATIONS FOLLOWING CHEMOTHERAPY

To cite this article:

Fashafsha ZZ, Mesitskaya DF, Kopylov FIu, Salpagarova ZK, Bykova AA. Diagnostic aspects of cardiovascular complications following chemotherapy. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(1):40‑45. (In Russ.)
https://doi.org/10.17116/kardio20221501140

 
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Opti­mal cardioplegia for coro­nary artery bypass grafting in patients with heart failure: a randomized study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):405-411
Evaluation of the skeletal muscle index in predicting toxic complications of anti­tumor drug therapy in patients with gastric cancer. P.A. Herzen Journal of Onco­logy. 2025;(4):29-36
Small cell carcinoma of the paro­tid gland. P.A. Herzen Journal of Onco­logy. 2025;(4):69-74
Cardiogenic deme­ntia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):43-49
The Webiomed.DHRA deci­sion-making support system for medi­cal examinations in the Russian Fede­ration: a cost-effectiveness analysis. Medi­cal Technologies. Asse­ssment and Choice. 2025;(3):61-73
Visceral obesity is a reve­rsible factor in pathogenesis of major cardiovascular diseases. Russian Cardiology Bulletin. 2025;(3):11-16
Systemic toxi­city of local anesthetics. Clinical guidelines of the All-Russian public orga­nization «Federation of anesthesiologists and reanimatologists». Russian Journal of Anesthesiology and Reanimatology. 2025;(5):8-21
Resu­lts of testing an antioxidant gel film for the prevention and treatment of palmar-plantar syndrome in cancer patients. P.A. Herzen Journal of Onco­logy. 2025;(5):59-63
Gender features of the vascular wall condition in young people with the body weight excess. Russian Journal of Preventive Medi­cine. 2025;(11):52-58
Predictive significance of the calcium index in asse­ssing cardiovascular risk. Russian Journal of Preventive Medi­cine. 2025;(11):79-85
Abstract:

Monitoring of cancer patients and assessment of risk of cardiovascular toxicity of chemotherapy are carried out using standard diagnostic methods including electrocardiography, echocardiography with analysis of global longitudinal strain and cardiac biomarkers. These techniques can identify subclinical heart damage before clinical manifestation. To achieve higher survival rates, it is necessary to ensure availability of diagnostic techniques using a single-channel ECG monitor, especially for elderly patients.

Keywords:

cardio-oncology
cardiovascular risk
cardiovascular toxicity
chemotherapy
heart failure
remote single-channel electrocardiography

Authors:

Fashafsha Z.Z.

Sechenov First Moscow State Medical University

Mesitskaya D.F.

Sechenov First Moscow State Medical University

Kopylov F.Iu.

Sechenov First Moscow State Medical University

Salpagarova Z.K.

Sechenov First Moscow State Medical University

Bykova A.A.

Sechenov First Moscow State Medical University

Received:

27.09.2021

Accepted:

11.11.2021

Close metadata

References:

  1. https://www.who.int/ru/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
  2. Kaprin AD, Starinskiy VV, Shakhzadova AO. Cancer care for population of Russia in 2019. M.: MNIOI them. P.A. Herzen — branch of the National Medical Research Center of Radiology of the Ministry of Health of Russia. 2020;239. (In Russ.).
  3. Vitsenya MV, Ageev FT, Gilyarov MYu, Ovchinnikov AG, Orlova RV, Poltavskaya MG. Guidelines for the management of cardiovascular toxicity of cancer therapy. Malignant tumors. 2020;10:3:66-87. (In Russ.).
  4. Plana JC, Galderisi M, et al. Expertconsensus for multimodality imaging evaluation ofadult patients during and after cancer therapy. J Am Soc Echocardiogr. 2014;27:9:911-939.  https://doi.org/10.1016/j.echo.2014.07.012
  5. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Russian Journal of Cardiology. 2017;22:105-139. (In Russ.).
  6. Yu Kang, Marielle Scherrer-Crosbie. Echocardiography Imaging of Cardiotoxicity. Cardiol Clin. 2019;37:4:419-427.  https://doi.org/10.1016/j.ccl.2019.07.006
  7. Bonneterre J, Roché H, Kerbrat P, et al. Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide. J Clin Oncol. 2004;22:15:3070-3079. https://doi.org/10.1200/jco.2004.03.098
  8. Timm KN, Tyler DJ. The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity. Cardiovasc Drugs Ther. 2020;34:2:255-269.  https://doi.org/10.1007/s10557-020-06941-x
  9. Iqubal A, Mohammad KI, et al. Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision. Life Sc. 2019;218:112-131.  https://doi.org/10.1016/j.lfs.2018.12.018
  10. Prus YuA, Sergienko IV, Kukharchuk VV, Fomin DK. Cardiovascular toxicity induced by chemotherapy and radiotherapy. Atherosclerosis and Dyslipidemia. 2017;3:56-72. (In Russ.).
  11. Bovelli D, et al. Minimum Clinical Guidelines of the European Society for Medical Oncology. M. 2010;423-433. (In Russ.).
  12. Matyash MG, Kravchuk TL, Vysotskaya VV, Chernov VI, Goldberg VE. Anthracyclines-induced cardiovascular toxicity: mechanisms of development and clinical manifestations. Siberian oncological journal. 2008;6:66-73. (In Russ.).
  13. Cancer drugs and the heart: importance and management. Thomas M. Suter, Michael S. Ewer European Heart Journal. 2013;34:15:1102-1111. https://doi.org/10.1093/eurheartj/ehs181
  14. Howlader N, Ries LAG, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102:1584-1598. https://doi.org/10.1093/jnci/djq366
  15. Larsen CM, Mulvagh SL. Cardio-oncology: what you need to know now for clinical practice and echocardiography. Echo RES Praf. 2017;4:1:33-41.  https://doi.org/10.1530/ERP-17-0013
  16. Lyon AR, Dent S, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies. Eur J Heart Fail. 2020;22:11:1945-1960. https://doi.org/10.1002/ejhf.1920
  17. Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clinic Proceedings. 2014;89:9:1287-1306. https://doi.org/10.1016/j.mayocp.2014.05.013
  18. Sawaya H, Sebag IA, Plana JC, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107:1375-1380. https://doi.org/10.1016/j.amjcard.2011.01.006
  19. Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston, et al. 2014 2013 AHA/ACC guidelines on lifestyle management to reduce cardiovascular risk. Circulation. 129:76-99.  https://doi.org/10.1161/01.cir.0000437740.48606.d1
  20. Zamorano JL, Lancellotti P, et al. ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. European Heart Journal. 2016;37:2768-2801. https://doi.org/10.1093/eurheartj/ehw211
  21. Spînu S, Cismaru G, et al. ECG Markers of Cardiovascular Toxicity in Adult and Pediatric Cancer Treatment. Dis Markers. 2021;2021:6653971. https://doi.org/10.1155/2021/6653971
  22. Varterasian M, Meyer M, Fingert H, et al. Baseline heart rate-corrected QT and eligibility for clinical trials in oncology. Journal of Clinical Oncology. 2003;21:17:3378-3379. https://doi.org/10.1200/JCO.2003.99.104
  23. Kim PY, Ewer MS. Chemotherapy and QT prolongation: overview with clinical perspective. Current Treatment Options in Cardiovascular Medicine. 2014;16:5:303.  https://doi.org/10.1007/s11936-014-0303-8
  24. Porta-Sánchez A, Gilbert C, Spears D, et al. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review. J Am Heart Assoc. 2017;6:12:e007724. https://doi.org/10.1161/JAHA.117.007724
  25. Bikiewicz A, Banach M, et al. Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications. ESC Heart Fail. 2021;8:2397-2418. https://doi.org/10.1002/ehf2.13365
  26. Plana JC, Galderisi M, Barac A, Ewer, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy. Eur Heart J Cardiovasc Imaging. 2014;15:1063-1093. https://doi.org/10.1093/ehjci/jeu192
  27. Curigliano G, Lenihan D, Fradley M, Ganatra S, et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020;31:171-190.  https://doi.org/10.1016/j.annonc.2019.10.023
  28. Armenian SA, Lacchetti C, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2017;35:893-911.  https://doi.org/10.1200/JCO.2016.70.5400
  29. Thavendiranathan P, Grant AD, et al. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61:1:77-84.  https://doi.org/10.1016/j.jacc.2012.09.035
  30. Walker J, Bhullar N, Fallah-Rad N, Lytwyn M, Golian M, Fang T, et al. Role of three-dimensional echocardiography in breast cancer. J Clin Oncol. 2010;28:21:3429-3436. https://doi.org/10.1200/JCO.2009.26.7294
  31. Thakur A, Witteles RM. Cancer therapy-induced left ventricular dysfunction: interventions and prognosis. J Card Fail. 2014;20:155-158.  https://doi.org/10.1016/j.cardfail.2013.12.018
  32. Jacobs LD, Salgo IS, et al. Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data. Eur Heart J. 2006;27:4:460-468.  https://doi.org/10.1093/eurheartj/ehi666
  33. Ganame J, Claus P, et al. Acute cardiac functional and morphological changes after Anthracycline infusions in children. Am J Cardiol. 2007;99:7:974-977.  https://doi.org/10.1016/j.amjcard.2006.10.063
  34. Laufer-Perl M, Derakhshesh M, et al. Usefulness of global longitudinal strain for early identification of subclinical left ventricular dysfunction in patients with active cancer. Am J Cardiol. 2018;122:1784-1789. https://doi.org/10.1016/j.amjcard.2018.08.019
  35. Arciniegas Calle MC, Sandhu NP, et al. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. BMC Cancer. 2018;18:1037. https://doi.org/10.1186/s12885-018-4935-z
  36. Castelletti S, Winkel BG, Schwartz PJ. Remote Monitoring of the QT Interval and Emerging Indications for Arrhythmia Prevention. Card Electrophysiol Clin. 2021;13:3:523-530.  https://doi.org/10.1016/j.ccep.2021.04.010
  37. Sagirova Z, Kuznetsova N, et al. Cuffless Blood Pressure Measurement Using a Smartphone-Case Based ECG Monitor with Photoplethysmography in Hypertensive Patients. Sensors. 2021;21:3525. https://doi.org/10.3390/s21103525
  38. Sagirova ZhN, Kuznetsova NO, Larionov VB, Chomakhidze PSh, Kopylov FYu, Syrkin AL. Pulse wave parameters in assessment of left ventricular systolic function. Kardiologiya i Serdechno-sosudistaya Khirurgiya. 2020;13:3:253-257. (In Russ.). https://doi.org/10.17116/kardio202013031253
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.